ARTICLE | Management Tracks
Jeito names Pascal Touchon as operating partner
Plus: Co-founder, CBO Grimaud leaving Valneva and new CMO for Context Therapeutics
June 5, 2025 12:17 AM UTC
European venture firm Jeito Capital named Pascal Touchon as its newest operating partner. Touchon, a former CEO of cell therapy company Atara Biotherapeutics Inc. (NASDAQ:ATRA), remains that company’s chairman. He represents Jeito on the board of Catalym GmbH, and holds board seats at Ipsen Group (Euronext:IPN; Pink:IPSEY), Medincell S.A. (Euronext:MEDCL) and CDR-Life Inc.
Vaccine developer Valneva SE (Euronext:VLA; NASDAQ:VALN) said co-founder and CBO Franck Grimaud will leave the company June 25. Grimaud has been with Valneva and predecessor company Vivalis S.A. for 26 years; Valneva was formed via the 2012 merger of Vivalis with Intercell AG...